These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 18347197)

  • 1. Does erythropoietin promote tumor growth?
    Yoon D; Agarwal N; Prchal JT
    Clin Cancer Res; 2008 Mar; 14(6):1920; author reply 1920-1. PubMed ID: 18347197
    [No Abstract]   [Full Text] [Related]  

  • 2. [Tumor-associated prognostic parameters in non-small-cell bronchial carcinoma].
    Thomas M
    Pneumologie; 1997 Jul; 51(7):669-77. PubMed ID: 9333800
    [No Abstract]   [Full Text] [Related]  

  • 3. Pleural effusion in patients with non-small cell carcinoma--stage IV and not T4.
    Alon BN; Anson BL
    Lung Cancer; 2007 Jul; 57(1):123. PubMed ID: 17445946
    [No Abstract]   [Full Text] [Related]  

  • 4. New TNM classification for non-small-cell lung cancer.
    Tanoue LT; Detterbeck FC
    Expert Rev Anticancer Ther; 2009 Apr; 9(4):413-23. PubMed ID: 19374596
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is primary resection of stage IIIA lung cancer futile?
    Grannis FW
    Ann Thorac Surg; 2008 Jul; 86(1):353-4; author reply 354. PubMed ID: 18573468
    [No Abstract]   [Full Text] [Related]  

  • 6. Prognostic significance of visceral pleural invasion and tumor size in non-small cell lung cancer.
    Hung JJ; Liu JS; Hsu WH
    J Thorac Cardiovasc Surg; 2009 Jul; 138(1):260-1. PubMed ID: 19577109
    [No Abstract]   [Full Text] [Related]  

  • 7. Prognostic significance of fluorodeoxyglucose uptake in non-small cell lung cancer. A blurry picture?
    Weber WA; Czernin J; Phelps ME
    Clin Cancer Res; 2007 Jun; 13(11):3105-6. PubMed ID: 17545510
    [No Abstract]   [Full Text] [Related]  

  • 8. Circulating miRNA signatures: promising prognostic tools for cancer.
    Heneghan HM; Miller N; Kerin MJ
    J Clin Oncol; 2010 Oct; 28(29):e573-4; author reply e575-6. PubMed ID: 20697097
    [No Abstract]   [Full Text] [Related]  

  • 9. Tumor expression of S100A6 correlates with survival of patients with stage I non-small-cell lung cancer.
    De Petris L; Orre LM; Kanter L; Pernemalm M; Koyi H; Lewensohn R; Lehtiö J
    Lung Cancer; 2009 Mar; 63(3):410-7. PubMed ID: 18620780
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Centromere protein H is a novel prognostic marker for human nonsmall cell lung cancer progression and overall patient survival.
    Liao WT; Wang X; Xu LH; Kong QL; Yu CP; Li MZ; Shi L; Zeng MS; Song LB
    Cancer; 2009 Apr; 115(7):1507-17. PubMed ID: 19170237
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Invited commentary.
    Pelosi G; Rosai J
    Ann Thorac Surg; 2008 Oct; 86(4):1090-1. PubMed ID: 18805137
    [No Abstract]   [Full Text] [Related]  

  • 12. Vascular endothelial growth factor polymorphisms in early-stage non-small-cell lung cancer.
    Patel M; Ailawadhi S; Hernandez-Ilizaliturri F; Wilding GE
    J Clin Oncol; 2008 Jul; 26(19):3289-90; author reply 3290. PubMed ID: 18591568
    [No Abstract]   [Full Text] [Related]  

  • 13. Results of primary surgery with T4 non-small cell lung cancer during a 25-year period in a single center: the benefit is worth the risk.
    Yildizeli B; Dartevelle PG; Fadel E; Mussot S; Chapelier A
    Ann Thorac Surg; 2008 Oct; 86(4):1065-75; discussion 1074-5. PubMed ID: 18805134
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Oncogenes, differentiation markers and morphological criteria as prognostic parameters in non-small-cell bronchial carcinoma].
    Thomas M; Junker K
    Dtsch Med Wochenschr; 1997 Oct; 122(43):1327-31. PubMed ID: 9410698
    [No Abstract]   [Full Text] [Related]  

  • 15. Angiogenetic biomarkers in non-small cell lung cancer with malignant pleural effusion: correlations with patient survival and pleural effusion control.
    Hsu IL; Su WC; Yan JJ; Chang JM; Lai WW
    Lung Cancer; 2009 Sep; 65(3):371-6. PubMed ID: 19157636
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of tumor size on non-size-based descriptors in staging of stage I non-small cell lung cancer.
    Ou SI; Zell JA
    Chest; 2009 Jun; 135(6):1695-1696. PubMed ID: 19497911
    [No Abstract]   [Full Text] [Related]  

  • 17. [Lung cancer in women: clinical features and factors related to survival].
    Sen E; Kaya A; Erol S; Savas I; Gonullu U
    Tuberk Toraks; 2008; 56(3):266-74. PubMed ID: 18932027
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Lung neoplasms--ultrasonic endoscopy as a first diagnostic tool].
    Pneumologie; 2008 Apr; 62(4):188. PubMed ID: 18393179
    [No Abstract]   [Full Text] [Related]  

  • 19. Do bone marrow isolated tumor cells influence long-term survival of non-small cell lung cancer?
    Ruffato A; Mattioli S; Pileri S; Daddi N; D'Ovidio F; Pilotti V; Tazzari P
    Eur J Cardiothorac Surg; 2009 Mar; 35(3):463-8. PubMed ID: 19150243
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Invited commentary.
    Korst RJ
    Ann Thorac Surg; 2006 Jul; 82(1):248. PubMed ID: 16798223
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.